Moonlake Immunotherapeutics (MLTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 334,517 | 180,426 | 451,169 | 39,506 | 8,039 |
| Marketable Securities | 59,451 | 267,601 | 59,839 | 32,609 | N/A |
| Receivables | 4,869 | 2,844 | 1,057 | 217 | 149 |
| TOTAL | $421,694 | $474,289 | $514,167 | $76,511 | $9,637 |
| Non-Current Assets | |||||
| PPE Net | 577 | 722 | 321 | 49 | 46 |
| Other Non-Current Assets | 2,162 | 2,922 | 12,052 | 283 | 0 |
| TOTAL | $2,739 | $3,644 | $12,373 | $332 | $46 |
| Total Assets | $424,433 | $477,933 | $526,540 | $76,843 | $9,683 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 15,000 |
| Accounts payable and accrued liabilities | 29,553 | 8,992 | 1,838 | 255 | 1,569 |
| Accrued Expenses | 14,691 | 12,099 | 6,930 | 7,257 | 4,518 |
| TOTAL | $45,478 | $22,463 | $9,966 | $7,665 | $21,088 |
| Non-Current Liabilities | |||||
| Long Term Debt | 74,100 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,377 | 4,387 | 11,155 | 14,944 | 240 |
| TOTAL | $74,474 | $2,079 | $3,083 | $411 | $240 |
| Total Liabilities | $119,952 | $24,542 | $13,049 | $8,077 | $21,328 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,728 | 64,012 | 63,887 | 52,701 | 14,805 |
| Common Shares | 7 | 6 | 6 | 5 | 39 |
| Retained earnings | -462,911 | -235,593 | -116,658 | -80,650 | -53,644 |
| Other shareholders' equity | 604 | 11,563 | 20,173 | 20,219 | -174 |
| TOTAL | $304,481 | $453,391 | $513,491 | $68,767 | $-11,645 |
| Total Liabilities And Equity | $424,433 | $477,933 | $526,540 | $76,843 | $9,683 |